Role of CCR4 ligands, CCL17 and CCL22, during Schistosoma mansoni egg-induced pulmonary granuloma formation in mice

被引:54
|
作者
Jakubzick, C
Wen, HT
Matsukawa, A
Keller, M
Kunkel, SL
Hogaboam, CM
机构
[1] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA
[2] Kumamoto Univ, Dept Pathol & Expt Med, Kumamoto, Japan
[3] Kumamoto Univ, Grad Sch Med Sci, Sch Med, Kumamoto, Japan
来源
AMERICAN JOURNAL OF PATHOLOGY | 2004年 / 165卷 / 04期
关键词
D O I
10.1016/S0002-9440(10)63381-0
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Controversy persists pertaining to the role of CCR4 ligands, namely CCL17 (or thymus and activation regulated chemokine; TARC) and CCL22 (or macrophage-derived chemokine; MDC), in Th2-type cytokine-dominated responses in the lung. Accordingly, the present study addressed the relative role of each of these CC chemokines during an evolving pulmonary granulomatous response elicited by the intrapulmonary embolization of live Schistosoma mansoni eggs into S. mansoni-sensitized mice. CCL22 protein expression peaked at day 4, but CCL17 levels were not increased significantly at any time after egg challenge. CCR4 transcript and protein expression were highest at day 8 after egg embolization and CCR4 protein was prominently expressed in macrophages surrounding S. mansoni eggs. Systemic immunoneutralization of CCL22 from the time of egg injection into S. mansoni-sensitized mice for 8 days significantly decreased CCR4 protein expression, the eosinophil content, the overall size of the egg granuloma, and its hydroxyproline content. Whole lung levels of interferon-gamma were also significantly increased at day 8 in anti-CCL22-treated mice. The systemic immunoneutralization of CCL17 had a lesser effect on all of the granuloma parameters listed above, but this antibody treatment significantly decreased granuloma hydroxyproline content to a greater extent than the anti-CCL22 antibody treatment. In addition, the immunoneutralization of CCL17 significantly increased whole lung levels of interleukin (IL)-4, IL-5, IL-13, transforming growth factor-beta, ILL-12, and tumor necrosis factor-a at day 8 after egg infusion. Thus, these studies demonstrate a major role for CCL22 and a lesser role for CCL17 during an evolving S. mansoni egg granuloma in the lung.
引用
收藏
页码:1211 / 1221
页数:11
相关论文
共 41 条
  • [1] CCL17, CCL22 and their receptor CCR4 in hematologic malignancies
    Zou, Shasha
    Liu, Bo
    Feng, Yonghuai
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [2] Expression of chemokine receptor CCR4 and its ligands (CCL17 and CCL22) in murine contact hypersensitivity
    Kusumoto, Mayumi
    Xu, Baohui
    Shi, Minyi
    Matsuyama, Takami
    Aoyama, Kohji
    Takeuchi, Toru
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2007, 27 (11): : 901 - 910
  • [3] Up-regulation of CCL17, CCL22 and CCR4 in drug-induced maculopapular exanthema
    Tapia, B.
    Morel, E.
    Martin-Diaz, M.-A.
    Diaz, R.
    Alves-Ferreira, J.
    Rubio, P.
    Padial, A.
    Bellon, T.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2007, 37 (05): : 704 - 713
  • [4] The C-C Chemokines CCL17 and CCL22 and Their Receptor CCR4 in CNS Autoimmunity
    Scheu, Stefanie
    Ali, Shafaqat
    Ruland, Christina
    Arolt, Volker
    Alferink, Judith
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (11):
  • [5] CCR4 Agonists CCL22 and CCL17 are Elevated in Pediatric OMS Sera: Rapid and Selective Down-Regulation of CCL22 by ACTH or Corticosteroids
    Michael R. Pranzatelli
    Elizabeth D. Tate
    Nathan R. McGee
    Jerry A. Colliver
    Richard M. Ransohoff
    Journal of Clinical Immunology, 2013, 33 : 817 - 825
  • [6] CCR4 Agonists CCL22 and CCL17 are Elevated in Pediatric OMS Sera: Rapid and Selective Down-Regulation of CCL22 by ACTH or Corticosteroids
    Pranzatelli, Michael R.
    Tate, Elizabeth D.
    McGee, Nathan R.
    Colliver, Jerry A.
    Ransohoff, Richard M.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2013, 33 (04) : 817 - 825
  • [7] CCL17 and CCL22 induce CCR4 receptor expression and promote cytokine-induced killer cells migration
    Dong, Yongjian
    Gao, Shuhui
    Zhang, Xuefang
    Kou, Jing
    Liu, Jing
    Ye, Ting
    Shen, Han
    ANTI-CANCER DRUGS, 2022, 33 (02) : 149 - 157
  • [8] Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis
    Yogo, Yurika
    Fujishima, Seitaro
    Inoue, Takashi
    Saito, Fumitake
    Shiomi, Takayuki
    Yamaguchi, Kazuhiro
    Ishizaka, Akitoshi
    RESPIRATORY RESEARCH, 2009, 10
  • [9] Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis
    Yurika Yogo
    Seitaro Fujishima
    Takashi Inoue
    Fumitake Saito
    Takayuki Shiomi
    Kazuhiro Yamaguchi
    Akitoshi Ishizaka
    Respiratory Research, 10
  • [10] The CCL22/CCR4 Axis Promotes Beige Adipocyte Formation
    Hu, Ruoci
    Park, Jooman
    Xiong, Shaolei
    Xu, Pingwen
    Jiang, Yuwei
    CIRCULATION, 2024, 150